Three-dimensional MR imaging and display of intracranial disease: improvements with the MP-RAGE sequence and gadolinium.
Three-dimensional (3D) image rendering was performed in 14 patients who had undergone magnetic resonance (MR) imaging for focal brain lesions. The MR study included the magnetization-prepared rapid gradient-echo (MP-RAGE) sequence with 64 or 128 partitions. Resultant contiguous sections 2.5 or 1.25 mm thick, respectively, were obtained. Images were acquired before and after administration of gadopentetate dimeglumine. Resultant 3D data sets were processed on a commercially available workstation. Correlative surgical observation was performed in four cases. All data sets were successfully processed into 3D images. The precontrast images proved superior to gadolinium-enhanced images for brain surface rendering. Postcontrast images proved superior for reconstruction of tumors and vascular structures. The 64-partition data set proved sufficient for all postprocessing. Coronal orientation was preferred to sagittal orientation for surface rendering because it provided optimal orthogonal orientation of sulcal and gyral brain surface features. Three-dimensional rendition allowed easy superposition of lesion, brain, vessels, and scalp features--all useful for surgical planning. The central sulcus was easily recognized in the midline partitions and traced mediolaterally for projection on the cortical surface. MP-RAGE provides a 3D data set that can be obtained in just over 3 minutes, from which clinically useful 3D renderings are possible. The rapidity of acquisition and capability for 3D rendering provides additional clinical utility.
Brant-Zawadzki
M N
MN
Department of Radiology, Hoag Memorial Hospital, Newport Beach, CA 92663.
Gillan
G D
GD
Atkinson
D J
DJ
Edalatpour
N
N
Jensen
M
M
D000293:Adolescent; D000328:Adult; D000465:Algorithms; D001921:Brain / Q000473:pathology*; D001927:Brain Diseases / Q000175:diagnosis*; D001932:Brain Neoplasms / Q000175:diagnosis*; D003287:Contrast Media; D004338:Drug Combinations; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008536:Meglumine; D008875:Middle Aged; D009942:Organometallic Compounds; D004369:Pentetic Acid
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D008536:Meglumine; D004369:Pentetic Acid; D019786:Gadolinium DTPA